| 99.49 |  +2.75 / +2.84% |
Data as of 4:00pm ET | Day’s Change |
| 99.88 | +0.3892 / +0.39% |
Volume: 3.6K |
| Shire PLC (SHPG): Today's Featured Health Care Winner 5:14pm / TheStreet.com | Shire Rises On Unusually High Volume (SHPG) May 20 / TheStreet.com |
| Positive Data on Roche Candidate - Analyst Blog May 22 / Zacks.com | 5 Drugs Stocks On The Rise May 20 / TheStreet.com |
| Previous close | 96.74 |
| Today’s open | 97.93 |
| Day’s range | 97.69 - 100.00 |
| Volume | 675,646 |
| Average volume (3 months) | 604,439 |
| Market cap | $17.9B |
| Dividend yield | 0.52% |
| Earnings growth (last year) | -14.55% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | +9.50% |
| Revenue growth (last year) | +9.69% |
| P/E ratio | NM |
| Price/Sales | 3.64 |
| Price/Book | 4.76 |
| Today’s change | Today’s % change | |
|---|---|---|
| VRTXVertex Pharmaceutica... | -0.08 | -0.10% |
| ACTActavis Inc | -0.85 | -0.66% |
| ZTSZoetis Inc | +0.62 | +1.89% |
| ALXNAlexion Pharmaceutic... | -0.71 | -0.71% |
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | $1.64 |
| Annual revenue (last year) | $4.7B |
| Annual profit (last year) | $746.8M |
| Net profit margin | 15.92% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chief Executive Officer & Director Flemming Ørnskov, MD, MBA |
CFO, Director, CAO & Investor Relations Contact Graham C. Hetherington |
Corporate headquarters Dublin, -- |
.
